Authors:
Nail, S
Robert, R
Dromer, F
Marot-Leblond, A
Senet, JM
Citation: S. Nail et al., Susceptibilities of Cryptococcus neoformans strains to platelet binding invivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro, INFEC IMMUN, 69(2), 2001, pp. 1221-1225
Authors:
Marot-Leblond, A
Robert, R
Loiseau, O
Apaire-Marchais, V
Senet, JM
Citation: A. Marot-leblond et al., Hydrophobic and hydrophilic cell surface (glyco)proteinic components of Candida albicans, J MYCOL MED, 10(3), 2000, pp. 115-122
Authors:
Viot, M
Blanc-Vincent, MP
Beal, J
Biron, P
Boutard, P
Malgrange, VB
Crokaert, F
Escande, MC
Fuhrmann, C
Lesimple, T
Peny, J
Pottecher, B
Raveneau, J
Senet, JM
Thyss, A
Citation: M. Viot et al., Infection and cancer: background and current issues, PRESSE MED, 29(29), 2000, pp. 1630-1633
Authors:
Malgrange, VB
Blanc-Vincent, MP
Escande, MC
Fuhrmann, C
Beal, J
Boineau, F
Biron, P
Crokaert, F
Lesimple, T
Pottecher, B
Raveneau, J
Senet, JM
Viot, M
Citation: Vb. Malgrange et al., Standards, options and guidelines for good clinical use of blood cultures in oncology, PRESSE MED, 29(27), 2000, pp. 1532-1534
Authors:
Bouterige, S
Robert, R
Bouchara, JP
Marot-Leblond, A
Molinero, V
Senet, JM
Citation: S. Bouterige et al., Production and characterization of two monoclonal antibodies specific for Plasmopara halstedii, APPL ENVIR, 66(8), 2000, pp. 3277-3282
Authors:
Pottecher, B
Herbrecht, R
BlancVincent, MP
Malgrange, VB
Escande, MC
Fuhrmann, C
Crokaert, F
GoryDelabaere, G
Senet, JM
Lesimple, T
Raveneau, J
Beal, J
Biron, P
Viot, M
Citation: B. Pottecher et al., Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology (vol 87, pg 557, 2000), B CANCER, 87(9), 2000, pp. 630-630
Authors:
Pottecher, B
Herbrecht, R
Blanc-Vincent, MP
Malgrange, VB
Escande, MC
Fuhrmann, C
Crokaert, F
Gory-Delabaere, G
Senet, JM
Lesimple, T
Raveneau, J
Beal, J
Biron, P
Viot, M
Citation: B. Pottecher et al., Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology, B CANCER, 87(7-8), 2000, pp. 557-591